Kessler Topaz Tapped To Lead Celgene Investor Suit
Kessler Topaz Meltzer & Check LLP has taken the helm of a securities class action accusing biotech company Celgene of hyping up the value of a trial drug for Crohn's disease...To view the full article, register now.
Already a subscriber? Click here to view full article